Pharmaceutical

Novo Holdings completes Catalent acquisition for $16.5bn

Dec 19, 2024

Novo Holdings has completed the previously announced acquisition of Catalent in ...

Pharma’s data and analytics market forecast to reach to...

Dec 19, 2024

A new report identifies data content management as the primary driver of growth ...

The healthcare sector must change its industrial refrig...

Dec 19, 2024

Industrial refrigeration is key to the healthcare industry, but it contributes m...

Abera and Orexo partner for vaccine powder formulations

Dec 19, 2024

Abera and Orexo have entered a partnership to develop and test the powder formul...

Petrovax announces positive results from long-CoV-III-2...

Dec 19, 2024

Small cell lung cancer: Navigating the global clinical ...

Dec 17, 2024

Discover the latest advancements in small cell lung cancer through Novotech CRO’...

EMA recommends expanding approval of Ofev to children a...

Dec 17, 2024

Boehringer Ingelheim’s blockbuster Ofev could be set for an expanded indication ...

Denmark’s HTA evolution

Dec 17, 2024

New HTA statistics produced by Denmark’s Medicinrådet for 2024 have prompted Glo...

Bavarian Nordic signs mpox vax deal with Serum Institut...

Dec 17, 2024

Bavarian Nordic has signed a licence and manufacturing agreement with the Serum ...

CTO Europe 2024: keep the burden of trials away from pa...

Dec 17, 2024

GSK’s lung cancer therapy gains EMA PRIME designation

Dec 17, 2024

GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for...

ADCs breach barriers to become mainstream cancer treatment

Dec 17, 2024

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) ...

FDA approves Galderma’s Nemluvio to treat atopic dermat...

Dec 17, 2024

The US FDA has approved Galderma's Nemluvio (nemolizumab), for individuals aged ...

The future of third-party logistics in an evolving biop...

Dec 17, 2024

The biopharmaceutical industry faces a future full of risks and rewards. But wha...

Reprieve for WuXi as Biosecure vote likely pushed to 2025

Dec 17, 2024

WuXi AppTec and WuXi Biologics are looking to sell off sites in the US and Europ...